tradingkey.logo
tradingkey.logo
Search

Conmed slips after Needham downgrade

ReutersJun 12, 2025 2:06 PM
facebooktwitterlinkedin
View all comments0

Shares of medical tech firm Conmed CNMD.N slip 3.4% to $54.99

Brokerage Needham downgrades rating to "hold" from "buy", saying company's long-term growth rate has decreased, meaning slower EPS growth with debt levels limiting its ability to expand new growth drivers or repurchase shares

Needham says it defended CNMD for trading at substantial discount to peers but its price-to-earnings ratio nearing that of peers led to rating cut

Average rating of six analysts is "hold"; median PT is $61 - data compiled by LSEG

As of last close, CNMD down 16.8% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI